leisure time -WSS

leisure time

author：fashion 2025-10-02 23:48:18 - browse：729

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Medicare has a new plan to address drug shortages

WSS

Vaccine advisory panel ACIP left half staffed by HHS

How digital tools helped lower hypertension in marginalized patients

Group opposing PBM reform sets lobbying record

Doctors' information doesn't help them choose wisely when sick

AI can’t replace a physician’s gut feeling

Gilead might be held responsible for not developing a drug

hotspot

leisure time

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Private equity deals in Medicare Advantage declines

Bright Health sells Medicare Advantage business to Molina

Doctors' information doesn't help them choose wisely when sick

Dobbs anniversary: the lost opportunity of abortion as health care

As digital health tech proliferates, a new institute aims to cut through hype

BioMarin wins approval for gene therapy to treat hemophilia A

Robert F. Kennedy is pitching centrism on health, even on abortion

Anesthesiologist group: stop taking Ozempic before surgery

Medicare Advantage proposed rates disappoint insurers

leisure time

WHO calls for emergency meeting on new China virus, as cases spread

'Revelatory' study finds a smoking impact that remains after quitting

Biden report: The neurospychology of memory and aging

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

FDA approves RSV monoclonal antibody for infants, toddlers

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

explore

focus

hotspot

entertainment